Am J Health Syst Pharm 1996; 53:1669-1685. Manufactured by:Baxter Healthcare CorporationDeerfield, IL 60015 USAFor Product Inquiry 1 800 ANA DRUG (1-800-262-3784)MLT-00065/4.0Protocol ADU-CL-02-v8Aduro Biotech, Inc. CRS-207 with Pemetrexed and Cisplatin Version 8, 08 March 2018 Page 128 page 7 of 9PACKAGE LABEL - PRINCIPAL DISPLAY PANEL Container Label NDC 10019-955-50 Cyclophosphamidefor Injection, USP500 mgCYTOTOXIC AGENTFOR SINGLE DOSE USESTERILE, NON-PYROGENICFOR PARENTERAL USERx only Baxter Manufactured by Baxter Healthcare CorporationDeerfield, IL 60015 USA460-629-01Protocol ADU-CL-02-v8Aduro Biotech, Inc. CRS-207 with Pemetrexed and Cisplatin Version 8, 08 March 2018 Page 129, N DC 10019-955-9:l m >< -0 Cyclophosphamlde for Injection, USP 500 mg CYTOTOXIC AGENT FOR SINGLE DOSE USE , S TERILE . NON-PYROOENIC only FOR PARENTERAL USE Baxter · P Aanuf!ciu re,:! bv BB.Il.r le~1bca111 CofiPo n li'on, Deerti~d. IL 6C015 USA 4E0-629 -01 Each vial contain s 500 mg cyclophoophamide. For· IV lrtlDsioo Use: Add 25 m L Sterile water for Injecti on, U SP , rnd shake = \ligo ro u sly to dissolve the drug, = Fo1 Dlrec:I lnjedion Use: Add 25 ml = 0.9% Sodium Chloride Injecti on, =.:i u U SP , and shake vigorously to dis-ii~ c::i solve the drug. =gl %Q - - co See insert for indications and dosa~ e = g [2 schfdule.